Haemonetics (HAE) Competitors

Haemonetics (NYSE:HAE) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation, community ranking and profitability.

Which has more volatility & risk, HAE or MMSI?

Haemonetics has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in HAE or MMSI?

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 1.8% of Haemonetics shares are held by insiders. Comparatively, 3.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community believe in HAE or MMSI?

Merit Medical Systems received 42 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 69.72% of users gave Merit Medical Systems an outperform vote while only 61.54% of users gave Haemonetics an outperform vote.

Company	Underperform	Outperform
Haemonetics	Outperform Votes 400 61.54%	Underperform Votes 250 38.46%
Merit Medical Systems	Outperform Votes 442 69.72%	Underperform Votes 192 30.28%

Does the media prefer HAE or MMSI?

In the previous week, Haemonetics had 12 more articles in the media than Merit Medical Systems. MarketBeat recorded 17 mentions for Haemonetics and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.49 beat Haemonetics' score of 0.71 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate HAE or MMSI?

Haemonetics presently has a consensus target price of $101.67, indicating a potential upside of 61.43%. Merit Medical Systems has a consensus target price of $109.80, indicating a potential upside of 6.44%. Given Haemonetics' higher probable upside, equities research analysts clearly believe Haemonetics is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.78
Merit Medical Systems	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00

Is HAE or MMSI more profitable?

Haemonetics has a net margin of 9.47% compared to Merit Medical Systems' net margin of 9.05%. Haemonetics' return on equity of 23.66% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	9.47%	23.66%	8.82%
Merit Medical Systems	9.05%	15.61%	8.38%

Which has higher valuation and earnings, HAE or MMSI?

Haemonetics has higher revenue and earnings than Merit Medical Systems. Haemonetics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.31B	2.42	$117.56M	$2.54	24.79
Merit Medical Systems	$1.26B	4.78	$94.41M	$2.04	50.57

Summary

Haemonetics and Merit Medical Systems tied by winning 9 of the 18 factors compared between the two stocks.